TIDEL-II : fi rst-line use of imatinib in CML with early...

  • Main
  • TIDEL-II : fi rst-line use of imatinib...

TIDEL-II : fi rst-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets

Yeung, David T, Osborn, Michael P, White, Deborah L, Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K, Hertzberg, Mark, Schwarer, Anthony P, Filshie
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
125
Year:
2015
Language:
english
DOI:
10.1182/blood-2014-07-590315.Presented
File:
PDF, 966 KB
english, 2015
Conversion to is in progress
Conversion to is failed